Chitosan-chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue SUPPL. 3, 2012, Pages

  Santo, Vítor E ^a   Gomes, Manuela E ^a   Mano, João F ^a   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Adipose derived stem cells; Controlled release; Nanoparticles; Platelet lysates; Regenerative medicine

Indexed keywords

BONE; CHITOSAN; ENCAPSULATION; ENZYME ACTIVITY; PLATELETS; REGENERATIVE MEDICINE; STEM CELLS; SULFUR COMPOUNDS; TISSUE ENGINEERING;

ADIPOSE DERIVED STEM CELLS; CHONDROITINSULFATE; CONTROLLED RELEASE; CONTROLLED-DELIVERY; GROWTH FACTOR; HUMAN ADIPOSE; IN-VITRO; PLATELET LYSATE; PROTEIN FACTORS; REGENERATIVE MEDICINE;

NANOPARTICLES;

CARRIER PROTEIN; CHITOSAN; CHONDROITIN SULFATE; GROWTH FACTOR; NANOCARRIER; NANOPARTICLE; NUCLEOTIDE; PLATELET LYSATES; RHODAMINE B; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BONE MINERALIZATION; BONE REGENERATION; BONE TISSUE; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSIS; NANOENCAPSULATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION; REGENERATIVE MEDICINE; SCANNING ELECTRON MICROSCOPY; STATIC ELECTRICITY; THROMBOCYTE; TISSUE ENGINEERING;

EID: 84871429935     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1519     Document Type: Article

References (77)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004; Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100(1): 5-28.
2. Amidi M, Mastrobattista E, Jiskoot W, et al. 2009; Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62(1): 59-82.
3. Anitua E, Sanchez M, Orive G. 2010; Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62(7-8): 741-752.
4. Balmayor ER, Feichtinger GA, Azevedo HS, et al. 2009; Starch-poly-ε-caprolactone microparticles reduce the needed amount of BMP-2. Clin Orthop Relat Res 467(12): 3138-3148.
5. Bessa PC, Balmayor ER, Azevedo HS, et al. 2010a; Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 4(5): 349-355.
6. Bessa PC, Casal M, Reis RL. 2008; Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2(2-3): 81-96.
7. Bessa PC, Machado R, Nurnberger S, et al. 2010b; Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J Control Release 142(3): 312-318.
8. Bosman FT, Stamenkovic I. 2003; Functional structure and composition of the extracellular matrix. J Pathol 200(4): 423-428.
9. Brochhausen C, Lehmann M, Halstenberg S, et al. 2009; Signalling molecules and growth factors for tissue engineering of cartilage - what can we learn from the growth plate? J Tissue Eng Regen Med 3(6): 416-429.
10. Cai C, Bakowsky U, Rytting E, et al. 2008; Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein. Eur J Pharm Biopharm 69(1): 31-42.
11. Causa F, Netti PA, Ambrosio L. 2007; A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analogue. Biomaterials 28(34): 5093-5099.
12. Chen FM, Zhang M, Wu ZF. 2010; Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31(24): 6279-6308.
13. Chen YL, Lee HP, Chan HY, et al. 2007; Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds for cartilage tissue engineering. Biomaterials 28(14): 2294-2305.
14. Chevallier N, Anagnostou F, Zilber S, et al. 2010; Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31(2): 270-278.
15. Choi BH, Im CJ, Huh JY, et al. 2004; Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg 33(1): 56-59.
16. Coviello T, Matricardi P, Marianecci C, et al. 2007; Polysaccharide hydrogels for modified release formulations. J Control Release 119(1): 5-24.
17. de la Fuente M, Seijo B, Alonso MJ. 2008; Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules. Macromol Biosci 8(5): 441-450.
18. Denuziere A, Ferrier D, Domard A. 1996; Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes. Physicochemical aspects. Carbohyd Polym 29(4): 317-323.
19. des Rieux A, Fievez V, Garinot M, et al. 2006; Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116(1): 1-27.
20. Di Martino A, Sittinger M, Risbud MV. 2005; Chitosan: a versatile biopolymer for orthopaedic tissue engineering. Biomaterials 26(30): 5983-5990.
21. Dimitriou R, Tsiridis E, Giannoudis PV. 2005; Current concepts of molecular aspects of bone healing. Injury 36(12): 1392-1404.
22. Duceppe N, Tabrizian M. 2009; Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials 30(13): 2625-2631.
23. Fundueanu G, Nastruzzi C, Carpov A, et al. 1999; Physicochemical characterization of Ca-alginate microparticles produced with different methods. Biomaterials 20(15): 1427-1435.
24. Gan Q, Wang T. 2007; Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 59(1): 24-34.
25. Gan Q, Wang T, Cochrane C, et al. 2005; Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 44(2-3): 65-73.
26. Gazori T, Khoshayand MR, Azizi E, et al. 2009; Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization. Carbohyd Polym 77(3): 599-606.
27. Grenha A, Gomes ME, Rodrigues M, et al. 2010; Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A 92(4): 1265-1272.
28. Grenha A, Seijo B, Serra C, et al. 2007; Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization. Biomacromolecules 8(7): 2072-2079.
29. Guliyeva U, Oner F, Ozsoy S, et al. 2006; Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm 62(1): 17-25.
30. Hartig SM, Greene RR, DasGupta J, et al. 2007; Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res 24(12): 2353-2369.
31. Hosseinkhani H, Tabata Y. 2006; Self-assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. J Nanosci Nanotechnol 6(8): 2320-2328.
32. Intini G. 2009; The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 30(28): 4956-4966.
33. Janes KA, Calvo P, Alonso MJ. 2001; Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47(1): 83-97.
34. Kean T, Thanou M. 2009; Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62(1): 3-11.
35. Kidane A, Bhatt PP. 2005; Recent advances in small molecule drug delivery. Curr Opin Chem Biol 9(4): 347-351.
36. Kumari A, Yadav SK, Yadav SC. 2010; Biodegradable polymeric nanoparticles-based drug delivery systems. Colloids Surf B Biointerfaces 75(1): 1-18.
37. Lin YC, Tan FJ, Marra KG, et al. 2009; Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications. Acta Biomater 5(7): 2591-2600.
38. Liu Z, Jiao Y, Wang Y, et al. 2008; Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60(15): 1650-1662.
39. Machado CB, Ventura JM, Lemos AF, et al. 2007; 3D chitosan-gelatin-chondroitin porous scaffold improves osteogenic differentiation of mesenchymal stem cells. Biomed Mater 2(2): 124-131.
40. Mailander V, Landfester K. 2009; Interaction of nanoparticles with cells. Biomacromolecules 10(9): 2379-2400.
41. Majeti NVRK. 2000; A review of chitin and chitosan applications. React Funct Polym 46(1): 1-27.
42. Malafaya PB, Oliveira JT, Reis RL. 2010; The effect of insulin-loaded chitosan particle-aggregated scaffolds in chondrogenic differentiation. Tissue Eng Part A 16(2): 735-747.
43. Mano JF, Silva GA, Azevedo HS, et al. 2007; Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 4(17): 999-1030.
44. Manton KJ, Haupt LM, Vengadasalam K, et al. 2007; Glycosaminoglycan and growth factor-mediated murine calvarial cell proliferation. J Mol Histol 38(5): 415-424.
45. Mao S, Sun W, Kissel T. 2010; Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62(1): 12-27.
46. Muir H. 1969; The structure and metabolism of mucopolysaccharides (glycosaminoglycans) and the problem of the mucopolysaccharidoses. Am J Med 47(5): 673-690.
47. Panda AK, Bhowmik BB, Das AR, et al. 2001; Dispersed molecular aggregates. 3. Synthesis and characterization of colloidal lead chromate in water/sodium bis(2-ethylhexyl)sulfosuccinate/n-heptane water-in-oil microemulsion medium. Langmuir 17(6): 1811-1816.
48. Park YJ, Lee YM, Lee JY, et al. 2000; Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release 67(2-3): 385-394.
49. Polson A. 1950; Some aspects of diffusion in solution and a definition of a colloidal particle. J Phys Colloid Chem 54(5): 649-652.
50. Prokop A, Davidson JM. 2008; Nanovehicular intracellular delivery systems. J Pharm Sci 97(9): 3518-3590.
51. Putney SD. 1998; Encapsulation of proteins for improved delivery. Curr Opin Chem Biol 2(4): 548-552.
52. Quaglia F. 2008; Bioinspired tissue engineering: the great promise of protein delivery technologies. Int J Pharm 364(2): 281-297.
53. Rada T, Reis RL, Gomes ME. 2009; Novel method for the isolation of adipose stem cells (ASCs). J Tissue Eng Regen Med 3(2): 158-159.
54. Rada T, Reis RL, Gomes ME. 2011; Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential. Stem Cell Rev 7(1): 64-76.
55. Richardson TP, Peters MC, Ennett AB, et al. 2001; Polymeric system for dual growth factor delivery. Nat Biotechnol 19(11): 1029-1034.
56. Ronca F, Palmieri L, Panicucci P, et al. 1998; Anti-inflammatory activity of chondroitin sulfate. Osteoarthr Cartilage 6(suppl A): 14-21.
57. Rosso F, Giordano A, Barbarisi M, et al. 2004; From cell-ECM interactions to tissue engineering. J Cell Physiol 199(2): 174-180.
58. Salvadè A, Mina PD, Gaddi D, et al. 2009; Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 16(2): 201-214.
59. Salvay DM, Shea LD. 2006; Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst 2(1): 36-48.
60. Santo VE, Frias AM, Carida M, et al. 2009; Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 10(6): 1392-1401.
61. Silva GA, Coutinho OP, Ducheyne P, et al. 2007a; Starch-based microparticles as vehicles for the delivery of active platelet-derived growth factor. Tissue Eng 13(6): 1259-1268.
62. Silva GA, Ducheyne P, Reis RL. 2007b; Materials in particulate form for tissue engineering. 1. Basic concepts. J Tissue Eng Regen Med 1(1): 4-24.
63. Simmons CA, Alsberg E, Hsiong S, et al. 2004; Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35(2): 562-569.
64. Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. 2001; Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1-2): 1-20.
65. Sui W, Huang L, Wang J, et al. 2008; Preparation and properties of chitosan-chondroitin sulfate complex microcapsules. Colloids Surf B Biointerfaces 65(1): 69-73.
66. Tabata Y. 2003; Tissue regeneration based on growth factor release. Tissue Eng 9(suppl 1): S5-S15.
67. Takahashi Y, Yamamoto M, Tabata Y. 2005; Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 26(23): 4856-4865.
68. Taylor KR, Gallo RL. 2006; Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20(1): 9-22.
69. Uebersax L, Merkle HP, Meinel L. 2009; Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev 15(3): 263-289.
70. Ueda H, Nakamura T, Yamamoto M, et al. 2003; Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor-β1. J Control Release 88(1): 55-64.
71. Visser LC, Arnoczky SP, Caballero O, et al. 2010; Growth factor-rich plasma increases tendon cell proliferation and matrix synthesis on a synthetic scaffold: an in vitro study. Tissue Eng Part A 16(3): 1021-1029.
72. Volpi N. 2006; Therapeutic applications of glycosaminoglycans. Curr Med Chem 13(15): 1799-1810.
73. Wiethoff CM, Smith JG, Koe GS, et al. 2001; The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J Biol Chem 276(35): 32806-32813.
74. Yamada Y, Ueda M, Naiki T, et al. 2004; Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10(5-6): 955-964.
75. Yilgor P, Tuzlakoglu K, Reis RL, et al. 2009; Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 30(21): 3551-3559.
76. Yuan N-Y, Tsai R-Y, Ho M-H, et al. 2008; Fabrication and characterization of chondroitin sulfate-modified chitosan membranes for biomedical applications. Desalination 234(1-3): 166-174.
77. Zaky SH, Ottonello A, Strada P, et al. 2008; Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2(8): 472-481.